Disease Modifying Genes in Severe Asthma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00212537
First received: September 19, 2005
Last updated: April 18, 2013
Last verified: April 2013

September 19, 2005
April 18, 2013
April 2002
January 2014   (final data collection date for primary outcome measure)
To recruit and characterize a cohort of subjects with asthma who reside in a high pollution, high asthma risk neighborhood [ Time Frame: five yeARS ] [ Designated as safety issue: Yes ]
Not Provided
Complete list of historical versions of study NCT00212537 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Disease Modifying Genes in Severe Asthma
Disease Modifying Genes in Severe Asthma

Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.

Not Provided
Observational
Observational Model: Case Control
Not Provided
Retention:   Samples With DNA
Description:

The total amount of blood drawn is approximately 5 tablespoons (75 ml). The blood sample will be processed to isolate "genetic material" (mainly DNA, RNA and protein). This genetic material will be used to try to identify the "genetic factors" or genes that a person inherits that make him or her more likely to develop asthma. The blood is used to test for allergies to weeds, trees, insects and molds (RAST) and a complete blood count.

Non-Probability Sample

All individuals approached for participation in the Research Registry shall be able to read or comprehend English. Since participation in the Research Registry does not involve a risk of physical harm, women of childbearing potential will not be queried as to pregnancy status or tested for pregnancy unless they are requested to undergo a methacholine challenge test. There are no additional inclusion/exclusion criteria.

Asthma
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
2000
Not Provided
January 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages 18 and above

Exclusion Criteria:

  • Greater than 10 pack year tobacco history
  • Lung diseases other than asthma
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00212537
H9698
Not Provided
New York University School of Medicine
New York University School of Medicine
Not Provided
Principal Investigator: Joan Reibman, MD NYU School of Medicine
New York University School of Medicine
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP